Agilent, Nonlinear Dynamics Pen Co-marketing Deal Involving Bioanalyzer, Analysis Software | GenomeWeb

NEW YORK, May 11 (GenomeWeb News) - Nonlinear Dynamics and Agilent Technologies have signed a co-marketing agreement involving Agilent's 2100 bioanalyzer platform and Nonlinear's TL 120 CM software, the companies said today.

 

Terms of the deal call for Nonlinear and Agilent to automate data exportation from Agilent's bioanalyzer for analysis, archiving, and data mining with Nonlinear's TL 120 DM software, the companies said.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.